NOTCH3 and Mental deterioration: The study will be completed across five centres in three states in Australia with an anticipated 150 NOTCH3 positive individuals (confirmed CADASIL, suspected CADASIL-either NOTCH3 positive or symptomatic) and equivalent NOTCH3 negative healthy controls without cognitive decline.